Articles by Optima Group Pharma GmbH - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Optima Group Pharma GmbH

Optima Group Pharma GmbH


Articles
Drastically reduced isolator decontamination cycles
February 27, 2013

With the use of catalytic aeration, M + P is able to reduce the duration of the aeration phase in isolators by about 50%. Those reduced and shortened isolator decontamination cycles have multiple advantages for the pharmaceutical industry.

Major Freeze Drying project for vials
September 25, 2012

The freeze drying systems are configured in a “C-type” design to ensure a particularly compact and spacesaving arrangement. The chamber and condenser are located one on top of the other, but are combined in a common housing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here